My links below :)
1 extracted signal · 1 resolved · 0 still active
Pip SnipersIndependent analyst profile- Source published
- 10 Jun 2025, 19:35 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis focuses on XTZUSD using a weekly chart. The composite operator distributed bags around the $5.79 to $7.08 supply zone between 2018 and 2022, then the market retraced to a demand zone around $0.059. Price has been moving sideways for almost 1000 days, showing time and price based capitulation and Wyckoff accumulation. Both sides of the range have been swept. Ascending accumulation is forming near the lows, typical before rapid expansion. Price is currently at the 38.2% Fibonacci level. If the daily candle closes above $0.61, price could reach the channel top around $0.77, or it could manipulate down to $0.48 before rallying. Overall, a move to the 61.8% retracement is expected, with a possible wick above the supply zone to $6.54. If the price manages to provide a daily close above $0.67, further retracements towards higher Fibonacci levels are probable. The analyst sees an expansion target to $3.00.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Pip Snipers
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
